Table of Content


Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360? synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of neurological disorders
3.2.1.2 Advancements in pain management technologies
3.2.1.3 Increase in awareness and diagnosis rates
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of advanced therapies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
3.10 Future market trends
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021-2034 ($ Mn)
5.1 Key trends
5.2 Surgical procedures
5.2.1 Radiofrequency thermal lesioning
5.2.2 Stereotactic radiosurgery
5.2.3 Microvascular decompression
5.2.4 Other surgical procedures
5.3 Medications
5.3.1 Anticonvulsants
5.3.2 Antidepressants
5.3.3 Other medications
Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 ($ Mn)
6.1 Key trends
6.2 Trigeminal neuralgia
6.3 Postherpetic neuralgia
6.4 Occipital neuralgia
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021-2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Ambulatory surgical centers
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 AA pharma
9.2 astellas
9.3 Biogen
9.4 Eli Lilly
9.5 Johnson & Johnson
9.6 Medtronic
9.7 NOVARTIS
9.8 PACIRA BIOSCIENCES
9.9 Pfizer
9.10 Siemens Healthineers